Shares of Vertex Pharmaceuticals Inc. VRTX slid 0.37% to $249.08 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.17% to 4,463.12 and the Dow Jones Industrial Average DJIA rising 0.80% to 34,754.93. The stock’s fall snapped a four-day winning streak. Vertex Pharmaceuticals Inc. closed $5.85 short of its 52-week high ($254.93), which the company reached on February 2nd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson JNJ fell 1.11% to $174.84, Merck & Co. Inc. MRK rose 0.22% to $79.11, and AbbVie Inc. ABBV rose 0.38% to $159.20. Trading volume (2.2 M) eclipsed its 50-day average volume of 1.7 M.